Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Renal cell carcinoma (RCC) is the most lethal of the common urological cancers, and is increasing in incidence globally. Bhatt and Finelli present a Timeline of landmarks in four centuries of research and treatment of RCC, the most common renal cancer, discussing current therapies and future prospects.
Non-muscle-invasive bladder cancer represents 75% of primary diagnoses and is characterized by frequent recurrence but a low risk of mortality. In this Timeline article, Mertens and colleagues discuss landmark events in the detection, diagnosis, and treatment of non-muscle-invasive bladder cancer.
BPH is one of the most common lower urinary tract diseases that predominantly affects men of advanced age. This Timeline article highlights the pivotal advances in BPH treatment (surgical and medical) from the late 19th century to the present day.
